Education
About Us
Working with TipRanks
Follow Us
Kyowa Kirin Co Ltd (JP:4151)
:4151
Kk2223
T-Cell Nhl (Ptcl Or Ctcl)
Phase I
Not Yet Recruiting
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Aug 12, 2025
―
Kk8398
Achondroplasia
Phase III
Recruiting
Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）
Apr 01, 2025
―
Kk3910
Healthy Volunteers Essential Hypertension
Phase I
Recruiting
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
Feb 07, 2025
―
Kk2845_1, Kk2845_2, Kk2845_3, Kk2845_4
Relapsed Or Refractory Acute Myeloid Leukemia
Phase I
Recruiting
Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Dec 23, 2024
―
Kk8123
X-Linked Hypophosphatemia
Phase I/II
Recruiting
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
May 10, 2024
―
Docetaxel, Kk2269
Advanced Solid Tumor, Non Small Cell Lung Cancer, Metastatic Solid Tumor, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma
Phase I
Recruiting
A Study of KK2269 in Adult Participants With Solid Tumors
Feb 05, 2024
―
Khk4951, Aflibercept Injection
Neovascular Age-Related Macular Degeneration (Namd)
Phase II
Recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
Oct 31, 2023
―
Khk4951, Aflibercept Injection
Diabetic Macular Edema (Dme)
Phase II
Recruiting
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
Oct 31, 2023
―
Kk2260
Advanced Or Metastatic Solid Tumors
Phase I
Recruiting
A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors
Sep 26, 2023
―
Kk4277
Healthy Volunteers, Systemic Lupus Erythematosus (Sle), Cutaneous Lupus Erythematosus (Cle)
Phase I
Active Not Recruiting
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
Jun 06, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kyowa Kirin Co Ltd (4151) have in its pipeline
4151 is currently developing the following drugs: Kk2223, Kk8398, Kk3910. These drug candidates are in various stages of clinical development as the company works toward FDA approval.